Does the media refer more to ICLR or CRL?

In the previous week, Charles River Laboratories International had 6 more articles in the media than Icon. MarketBeat recorded 11 mentions for Charles River Laboratories International and 5 mentions for Icon. Icon's average media sentiment score of 1.57 beat Charles River Laboratories International's score of 0.53 indicating that Icon is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Icon 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Charles River Laboratories International 5 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, ICLR or IQV?

IQVIA has higher revenue and earnings than Icon. IQVIA is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Icon $8.25B 1.60 $229.34M $4.26 40.43 IQVIA $16.31B 2.63 $1.36B $8.06 32.28

Is ICLR or IQV more profitable?

IQVIA has a net margin of 8.10% compared to Icon's net margin of 3.99%. IQVIA's return on equity of 30.25% beat Icon's return on equity. Company Net Margins Return on Equity Return on Assets Icon 3.99% 8.02% 4.56% IQVIA 8.10% 30.25% 6.54%

Does the media refer more to ICLR or IQV?

In the previous week, IQVIA had 21 more articles in the media than Icon. MarketBeat recorded 26 mentions for IQVIA and 5 mentions for Icon. Icon's average media sentiment score of 1.57 beat IQVIA's score of 1.49 indicating that Icon is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Icon 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive IQVIA 22 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor A or ICLR?

In the previous week, Agilent Technologies had 24 more articles in the media than Icon. MarketBeat recorded 29 mentions for Agilent Technologies and 5 mentions for Icon. Icon's average media sentiment score of 1.57 beat Agilent Technologies' score of 1.36 indicating that Icon is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilent Technologies 23 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Icon 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has preferable valuation & earnings, ICLR or WAT?

Waters has lower revenue, but higher earnings than Icon. Icon is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Icon $8.25B 1.60 $229.34M $4.26 40.43 Waters $3.17B 12.80 $642.63M $4.01 102.84

Is ICLR or WAT more profitable?

Icon has a net margin of 3.99% compared to Waters' net margin of 3.58%. Waters' return on equity of 11.27% beat Icon's return on equity. Company Net Margins Return on Equity Return on Assets Icon 3.99% 8.02% 4.56% Waters 3.58% 11.27% 6.73%

Does the media refer more to ICLR or WAT?

In the previous week, Waters had 17 more articles in the media than Icon. MarketBeat recorded 22 mentions for Waters and 5 mentions for Icon. Icon's average media sentiment score of 1.57 beat Waters' score of 1.39 indicating that Icon is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Icon 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Waters 16 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, ILMN or ICLR?

Illumina has higher earnings, but lower revenue than Icon. Icon is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Illumina $4.34B 7.63 $850M $5.36 40.93 Icon $8.25B 1.60 $229.34M $4.26 40.43

Is ILMN or ICLR more profitable?

Illumina has a net margin of 18.36% compared to Icon's net margin of 3.99%. Illumina's return on equity of 29.84% beat Icon's return on equity. Company Net Margins Return on Equity Return on Assets Illumina 18.36% 29.84% 12.17% Icon 3.99% 8.02% 4.56%

Does the media refer more to ILMN or ICLR?

In the previous week, Illumina had 39 more articles in the media than Icon. MarketBeat recorded 44 mentions for Illumina and 5 mentions for Icon. Icon's average media sentiment score of 1.57 beat Illumina's score of 1.16 indicating that Icon is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Illumina 34 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Icon 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Icon (ICLR) Competitors

$172.23 -2.03 (-1.16%)

As of 08/21/2026 04:00 PM Eastern

Compare

ICLR vs. CRL, IQV, A, WAT, and ILMN

Should you buy Icon stock or one of its competitors? Icon's main competitors and comparable companies include Charles River Laboratories International (CRL), IQVIA (IQV), Agilent Technologies (A), Waters (WAT), and Illumina (ILMN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Icon compare to Charles River Laboratories International?

Icon (NASDAQ:ICLR) and Charles River Laboratories International (NYSE:CRL) are both large-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, earnings, analyst recommendations and dividends.

Icon has a beta of 1.21, meaning that its stock price is 21% more volatile than the broader market. Comparatively, Charles River Laboratories International has a beta of 1.38, meaning that its stock price is 38% more volatile than the broader market.

95.6% of Icon shares are owned by institutional investors. Comparatively, 98.9% of Charles River Laboratories International shares are owned by institutional investors. 44.0% of Icon shares are owned by insiders. Comparatively, 1.3% of Charles River Laboratories International shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Icon has a net margin of 3.99% compared to Charles River Laboratories International's net margin of -5.96%. Charles River Laboratories International's return on equity of 15.75% beat Icon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Icon	3.99%	8.02%	4.56%
Charles River Laboratories International	-5.96%	15.75%	6.51%

Icon currently has a consensus target price of $170.40, suggesting a potential downside of 1.06%. Charles River Laboratories International has a consensus target price of $255.65, suggesting a potential downside of 13.41%. Given Icon's higher probable upside, research analysts clearly believe Icon is more favorable than Charles River Laboratories International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Icon	2 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.41
Charles River Laboratories International	1 Sell rating(s)	3 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.69

In the previous week, Charles River Laboratories International had 6 more articles in the media than Icon. MarketBeat recorded 11 mentions for Charles River Laboratories International and 5 mentions for Icon. Icon's average media sentiment score of 1.57 beat Charles River Laboratories International's score of 0.53 indicating that Icon is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Icon	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Charles River Laboratories International	5 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Icon has higher revenue and earnings than Charles River Laboratories International. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Icon	$8.25B	1.60	$229.34M	$4.26	40.43
Charles River Laboratories International	$4.02B	3.51	-$144.34M	-$4.85	N/A

Summary

Icon beats Charles River Laboratories International on 9 of the 17 factors compared between the two stocks.

How does Icon compare to IQVIA?

Icon (NASDAQ:ICLR) and IQVIA (NYSE:IQV) are both large-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, risk, dividends, profitability, analyst recommendations, earnings and valuation.

Icon has a beta of 1.21, meaning that its share price is 21% more volatile than the broader market. Comparatively, IQVIA has a beta of 1.18, meaning that its share price is 18% more volatile than the broader market.

Icon presently has a consensus price target of $170.40, suggesting a potential downside of 1.06%. IQVIA has a consensus price target of $241.88, suggesting a potential downside of 7.03%. Given Icon's higher possible upside, analysts plainly believe Icon is more favorable than IQVIA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Icon	2 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.41
IQVIA	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	1 Strong Buy rating(s)	2.88

IQVIA has higher revenue and earnings than Icon. IQVIA is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Icon	$8.25B	1.60	$229.34M	$4.26	40.43
IQVIA	$16.31B	2.63	$1.36B	$8.06	32.28

IQVIA has a net margin of 8.10% compared to Icon's net margin of 3.99%. IQVIA's return on equity of 30.25% beat Icon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Icon	3.99%	8.02%	4.56%
IQVIA	8.10%	30.25%	6.54%

In the previous week, IQVIA had 21 more articles in the media than Icon. MarketBeat recorded 26 mentions for IQVIA and 5 mentions for Icon. Icon's average media sentiment score of 1.57 beat IQVIA's score of 1.49 indicating that Icon is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Icon	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
IQVIA	22 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

95.6% of Icon shares are owned by institutional investors. Comparatively, 89.6% of IQVIA shares are owned by institutional investors. 44.0% of Icon shares are owned by company insiders. Comparatively, 1.7% of IQVIA shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

IQVIA beats Icon on 10 of the 16 factors compared between the two stocks.

How does Icon compare to Agilent Technologies?

Agilent Technologies (NYSE:A) and Icon (NASDAQ:ICLR) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, earnings, risk, media sentiment, valuation, analyst recommendations and institutional ownership.

Agilent Technologies has higher earnings, but lower revenue than Icon. Agilent Technologies is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilent Technologies	$6.95B	6.47	$1.30B	$4.98	31.98
Icon	$8.25B	1.60	$229.34M	$4.26	40.43

Agilent Technologies has a beta of 1.25, meaning that its stock price is 25% more volatile than the broader market. Comparatively, Icon has a beta of 1.21, meaning that its stock price is 21% more volatile than the broader market.

Agilent Technologies currently has a consensus price target of $160.24, indicating a potential upside of 0.62%. Icon has a consensus price target of $170.40, indicating a potential downside of 1.06%. Given Agilent Technologies' stronger consensus rating and higher possible upside, equities research analysts plainly believe Agilent Technologies is more favorable than Icon.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilent Technologies	0 Sell rating(s)	4 Hold rating(s)	13 Buy rating(s)	2 Strong Buy rating(s)	2.89
Icon	2 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.41

95.6% of Icon shares are held by institutional investors. 44.0% of Icon shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Agilent Technologies has a net margin of 19.55% compared to Icon's net margin of 3.99%. Agilent Technologies' return on equity of 24.33% beat Icon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilent Technologies	19.55%	24.33%	12.99%
Icon	3.99%	8.02%	4.56%

In the previous week, Agilent Technologies had 24 more articles in the media than Icon. MarketBeat recorded 29 mentions for Agilent Technologies and 5 mentions for Icon. Icon's average media sentiment score of 1.57 beat Agilent Technologies' score of 1.36 indicating that Icon is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilent Technologies	23 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Icon	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Agilent Technologies beats Icon on 12 of the 17 factors compared between the two stocks.

How does Icon compare to Waters?

Icon (NASDAQ:ICLR) and Waters (NYSE:WAT) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, media sentiment, dividends and earnings.

In the previous week, Waters had 17 more articles in the media than Icon. MarketBeat recorded 22 mentions for Waters and 5 mentions for Icon. Icon's average media sentiment score of 1.57 beat Waters' score of 1.39 indicating that Icon is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Icon	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Waters	16 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Icon has a net margin of 3.99% compared to Waters' net margin of 3.58%. Waters' return on equity of 11.27% beat Icon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Icon	3.99%	8.02%	4.56%
Waters	3.58%	11.27%	6.73%

Waters has lower revenue, but higher earnings than Icon. Icon is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Icon	$8.25B	1.60	$229.34M	$4.26	40.43
Waters	$3.17B	12.80	$642.63M	$4.01	102.84

Icon has a beta of 1.21, meaning that its stock price is 21% more volatile than the broader market. Comparatively, Waters has a beta of 1.19, meaning that its stock price is 19% more volatile than the broader market.

Icon currently has a consensus target price of $170.40, suggesting a potential downside of 1.06%. Waters has a consensus target price of $420.35, suggesting a potential upside of 1.94%. Given Waters' stronger consensus rating and higher possible upside, analysts plainly believe Waters is more favorable than Icon.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Icon	2 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.41
Waters	0 Sell rating(s)	8 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.75

95.6% of Icon shares are held by institutional investors. Comparatively, 94.0% of Waters shares are held by institutional investors. 44.0% of Icon shares are held by insiders. Comparatively, 0.3% of Waters shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Waters beats Icon on 10 of the 17 factors compared between the two stocks.

How does Icon compare to Illumina?

Illumina (NASDAQ:ILMN) and Icon (NASDAQ:ICLR) are both large-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and media sentiment.

Illumina has a beta of 1.45, meaning that its stock price is 45% more volatile than the broader market. Comparatively, Icon has a beta of 1.21, meaning that its stock price is 21% more volatile than the broader market.

Illumina has higher earnings, but lower revenue than Icon. Icon is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Illumina	$4.34B	7.63	$850M	$5.36	40.93
Icon	$8.25B	1.60	$229.34M	$4.26	40.43

Illumina currently has a consensus price target of $188.40, suggesting a potential downside of 14.13%. Icon has a consensus price target of $170.40, suggesting a potential downside of 1.06%. Given Icon's higher possible upside, analysts plainly believe Icon is more favorable than Illumina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Illumina	2 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.47
Icon	2 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.41

In the previous week, Illumina had 39 more articles in the media than Icon. MarketBeat recorded 44 mentions for Illumina and 5 mentions for Icon. Icon's average media sentiment score of 1.57 beat Illumina's score of 1.16 indicating that Icon is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Illumina	34 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Icon	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

89.4% of Illumina shares are held by institutional investors. Comparatively, 95.6% of Icon shares are held by institutional investors. 2.9% of Illumina shares are held by company insiders. Comparatively, 44.0% of Icon shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Illumina has a net margin of 18.36% compared to Icon's net margin of 3.99%. Illumina's return on equity of 29.84% beat Icon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Illumina	18.36%	29.84%	12.17%
Icon	3.99%	8.02%	4.56%

Summary

Illumina beats Icon on 11 of the 16 factors compared between the two stocks.

Get Icon News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ICLR vs. The Competition

Export

Metric	Icon	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$13.19B	$10.24B	$7.38B	$12.85B
Dividend Yield	N/A	1.45%	2.53%	10.78%
P/E Ratio	40.43	61.54	272.60	24.25
Price / Sales	1.60	110.82	623.26	100.89
Price / Cash	10.22	27.04	78.62	53.99
Price / Book	1.41	37.34	13.05	6.20
Net Income	$229.34M	$56.67B	$3.47B	$348.59M
7 Day Performance	5.57%	5.24%	2.09%	0.08%
1 Month Performance	1.12%	9.02%	6.63%	3.88%
1 Year Performance	-2.05%	24.45%	25.01%	16.98%

Icon Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ICLR Icon	3.5274 of 5 stars	$172.23 -1.2%	$170.40 -1.1%	-2.0%	$13.19B	$8.25B	40.43	40,100	Positive News
CRL Charles River Laboratories International	1.8779 of 5 stars	$286.44 +2.3%	$255.65 -10.8%	+82.7%	$13.68B	$4.00B	N/A	19,700	Trending News Insider Trade
IQV IQVIA	4.0723 of 5 stars	$241.09 +1.9%	$241.88 +0.3%	+36.2%	$39.71B	$16.98B	29.91	93,000	Positive News
A Agilent Technologies	4.5125 of 5 stars	$148.65 +0.1%	$160.24 +7.8%	+31.1%	$41.93B	$7.23B	29.85	18,100	News Coverage Positive News Upcoming Earnings
WAT Waters	2.8292 of 5 stars	$407.75 -1.1%	$420.35 +3.1%	+36.6%	$40.49B	$3.17B	101.68	7,900	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ICLR) was last updated on 8/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Icon (ICLR) Competitors

ICLR vs. CRL, IQV, A, WAT, and ILMN

How does Icon compare to Charles River Laboratories International?

Summary

How does Icon compare to IQVIA?

Summary

How does Icon compare to Agilent Technologies?

Summary

How does Icon compare to Waters?

Summary

How does Icon compare to Illumina?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ICLR vs. The Competition

Icon Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Icon (ICLR) Competitors

ICLR vs. CRL, IQV, A, WAT, and ILMN

How does Icon compare to Charles River Laboratories International?

Which has more volatility and risk, ICLR or CRL?

Do insiders and institutionals hold more shares of ICLR or CRL?

Is ICLR or CRL more profitable?

Do analysts rate ICLR or CRL?

Does the media refer more to ICLR or CRL?

Which has preferable earnings & valuation, ICLR or CRL?

Summary

How does Icon compare to IQVIA?

Which has more risk & volatility, ICLR or IQV?

Do analysts rate ICLR or IQV?

Which has stronger valuation & earnings, ICLR or IQV?

Is ICLR or IQV more profitable?

Does the media refer more to ICLR or IQV?

Do institutionals & insiders hold more shares of ICLR or IQV?

Summary

How does Icon compare to Agilent Technologies?

Which has preferable valuation & earnings, A or ICLR?

Which has more volatility & risk, A or ICLR?

Do analysts prefer A or ICLR?

Do insiders and institutionals hold more shares of A or ICLR?

Is A or ICLR more profitable?

Does the media favor A or ICLR?

Summary

How does Icon compare to Waters?

Does the media refer more to ICLR or WAT?

Is ICLR or WAT more profitable?

Which has preferable valuation & earnings, ICLR or WAT?

Which has more risk and volatility, ICLR or WAT?

Do analysts recommend ICLR or WAT?

Do insiders and institutionals have more ownership in ICLR or WAT?

Summary

How does Icon compare to Illumina?

Which has more risk and volatility, ILMN or ICLR?

Which has higher earnings & valuation, ILMN or ICLR?

Do analysts prefer ILMN or ICLR?

Does the media refer more to ILMN or ICLR?

Do institutionals & insiders have more ownership in ILMN or ICLR?

Is ILMN or ICLR more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ICLR vs. The Competition

Icon Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools